The use of hormone therapy was associated with a reduced risk of breast cancer in postmenopausal women who carry BRCA mutations, according to a case-control study.
Women who carry a mutation in the BRCA1 gene may opt to have their ovaries removed to lower their risk of developing breast cancer. The surgery, however, induces menopause, and thus some women opt to take hormone therapy to reduce its symptoms. The impact of hormone therapy on the risk of breast cancer in these women is not known.
Read more
Women who carry a mutation in the BRCA1 gene may opt to have their ovaries removed to lower their risk of developing breast cancer. The surgery, however, induces menopause, and thus some women opt to take hormone therapy to reduce its symptoms. The impact of hormone therapy on the risk of breast cancer in these women is not known.
Read more